Rob Van Dam would be open to discussing having an extended run in All Elite Wrestling if the conversation presented itself. On the latest episode of 1 Of A Kind with RVD, the WWE Hall of Famer ...

Khan announced on Twitter that Rob Van Dam will be on the 4/20 episode of Collision. Khan didn’t confirm what RVD will do on that show, but RVD on 4/20 seems like a great match.

Rob Van Dam will happily price himself out of the business before wrestling for lower than he believes he’s worth. Speaking on his One of a Kind Podcast, the former WWE Champion spoke about how ...

Still, RVD recalls being so burned out at the time that he greatly enjoyed his time recovering at home. If you use any of the quotes in this article, please credit "1 Of A Kind" with a h/t to ...

The worst Wrestlepalooza was the one in which ECW took the name to PPV, and it absolutely flopped. There was pretty much ...

RVD took note of the suggestion and expressed his willingness to consider the idea. He wants to fight him in an upcoming PPV match, which has thrown the notion of that match into the atmosphere ...

Rob Van Dam was featured on the September 13 episode of SmackDown. He detailed how his appearance came together on his 1 Of A Kind podcast and said he didn’t have much notice about the appearance.

Rob Van Dam isn’t backing down from his recent comments regarding Jon Moxley and All Elite Wrestling. On a recent episode of Rob Van Dam’s podcast, the WWE Hall of Famer spoke about the recent ...

If RVD was to go back to AEW for a match or two, he already has someone in mind that he would like to face, that being former AEW World Trios Champion Malakai Black.

Rob Van Dam, a man whose stellar career in ECW leaves a legacy of (chair) smashing performances, against Jungle Boy, the young, promising heir to the rebellious spirit of Taz's ECW regime.

Rob Van Dam is a WWE Hall of Famer and former WWE Champion and ECW Champion. He recently appeared on an episode of NXT, which took place in the 2300 Arena -- the old ECW stomping grounds in ...

At a median follow-up of 49.6 months, D-RVd reduced the risk of disease progression or death by 61% in Black patients and 53% in White patients, compared with RVd, investigators found.